[Results up to now of administration of STI-571 (Glivec) in recurrence after allogenic and autologous stem cell transplantation in chronic myeloid leukemia]. [electronic resource]
Producer: 20020325Description: 22-7 p. digitalISSN:- 0723-5003
- Adolescent
- Adult
- Antineoplastic Agents -- adverse effects
- Benzamides
- Child
- Clinical Trials as Topic
- Enzyme Inhibitors -- adverse effects
- Female
- Hematopoietic Stem Cell Transplantation
- Humans
- Imatinib Mesylate
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Male
- Middle Aged
- Piperazines -- adverse effects
- Pyrimidines -- adverse effects
- Remission Induction
- Treatment Outcome
No physical items for this record
Publication Type: English Abstract; Journal Article
There are no comments on this title.
Log in to your account to post a comment.